Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
algorithm
andexanet
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation, perioperative
anticonvulsants
arterial dissection
arterial dissection, carotid
arterial dissection, vertebral
aspirin
aspirin, restarting
atrial fibrillation
atrial fibrillation, risk stratification
basal ganglia, hemorrhage
blood pressure
blood pressure, control
blood pressure, lowering
breast feeding
bridge therapy
bronchoscopy
cardiomyopathy
carotid artery disease
carotid artery occlusion, perioperative
CAT scan, mass effect on
cataract surgery
cerebellar hemorrhage
cerebral atherosclerosis
cerebral embolism, cardiac origin
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, complications with
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, women
cerebrovascular accident, young adult
cerebrovascular disease, risk factors in
colonoscopy
complications
controversies in neurology
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
deafness, unilateral
delivery, complicated
dental procedure, neurologic complications with
efficacy
electromyogram
endarterectomy, carotid
endoscopic surgery
endoscopy
evidence-based research
factor Xa inhibitor
gastrointestinal bleeding
heart valve, prosthetic
heart valve, prosthetic, mechanical
hemorrhagic diathesis
heparin
hip arthroplasty
hormone replacement
hormone therapy
hydrocephalus
iatrogenic neurologic disorders
incidence
INR values
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, lobar
intracerebral hemorrhage, location of
intracerebral hemorrhage, progression of
intracerebral hemorrhage, recurrent
intracerebral hemorrhage, treatment of
intracranial pressure monitoring
intracranial pressure, increased
intraventricular hemorrhage
intraventricular hemorrhage, clot evacuation
intraventricular hemorrhage, treatment
invasive procedure
labor, complicated
life support, withdrawal of
menopause
mortality
MRI, CAT scan compared to
neurologic complications of, surgery
neurological intensive care
non-vitamin K antagonist oral anticoagulants
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
ovarian induction
pacemaker, cardiac-transvenous
patent foramen ovale
patient information and support
peri-procedural
platelet inhibiting drugs
platelet inhibiting drugs, discontinuation
platelet inhibiting drugs, restarting
postoperative neurologic complications
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
race
recurrent
review article
risk factors
risk stratification
risk-benefit assessment
safety
seizure
seizure, prevention of
sickle cell disease
stent, coronary artery
subdural hematoma
subdural hematoma, chronic
teratogenesis
teratogenic drugs
the metabolic syndrome
thrombophlebitis
thrombophlebitis, prophylaxis
transient ischemic attack
transluminal angioplasty, coronary artery
transurethral prostatectomy
treatment of neurologic disorder
valvulopathy
venous thrombosis, non-cerebral
ventriculostomy
ventriculostomy, endoscopic
workup
Showing articles 750 to 800 of 1030 << Previous Next >>

How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993

Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993

Role of Prophyl Anticoag for Direct Current Cardiover in Pts with Atrial Fib, Atrial Flutter
J Am Coll Cardiol 19:851-855, Zeiler,A.,et al, 1992

Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992

Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992

Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992

Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992

Lupus Anticoagulant and Anticardiolipin Antibodies in Young Adults with Cerebral Ischemia
Stroke 23:189-193, Nencini,P.,et al, 1992

Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992

Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992

Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992

Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992

Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992

Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992

Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992

European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992

Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992

Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage
Stroke 23:972-977, Fredriksson,K.,et al, 1992

Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992

A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992

Antiphospholipid Antibody Syndrome
JAMA 268:1451-1453, Lockshin,M.D., 1992

Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992

Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992

Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992

Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992

Carotid Endarterectomy:Recommendations for Manag of Transient Ischaemic Attack and Ischaemic Stroke
BMJ 305:1071-1074, Brown,M.M.,et al, 1992

Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992

Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992

Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992

Percutaneous Decompression for Femoral Neuropathy Secondary to Heparin-Induced Retroperitoneal Hematoma:Case Rpt & Review
Am Surg 57:706-710, Merrick,H.W.,et al, 1991

Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991

Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991

Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991

Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991

Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991

A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991

Dissection of the Extracranial Vertebral Artery:Report of Four Cases and Review of the Literature
JNNP 54:863-869, Hinse,P.,et al, 1991

Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991

Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991

Cerebral Ischemic Events Associated with Endocarditis, Retinal Vascular Disease, & Lupus Anticoagulant
Am J Med 90:299-309, Pope,J.M.,et al, 1991

Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991

Heparin Treatment in Sinus Venous Thrombosis
Lancet 338:597-600, Einhaupl,K.M.,et al, 1991

MRC European Carotid Surgery Trial:Results for (70-99% ) or with Mild (0-29% ) Carotid Stenosis
European Carotid Surg Group, Lancet 337:1235-1243, 1255-1256991., , 1991

Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991

Prognostic Parameters in Spontaneous Intracerebral Hematomas with Special Reference to Anticoagulant Treatment
Stroke 22:571-576, Radberg,J.A.,et al, 1991

Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991

The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991

Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991

Antiphospholipid Antibodies in Cerebral Ischemia
Stroke 22:750-753, Montalban,J.,et al, 1991



Showing articles 750 to 800 of 1030 << Previous Next >>